These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies. Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629 [TBL] [Abstract][Full Text] [Related]
5. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
6. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726 [TBL] [Abstract][Full Text] [Related]
7. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors. Sheng C; Zhu J; Zhang W; Zhang M; Ji H; Song Y; Xu H; Yao J; Miao Z; Zhou Y; Zhu J; Lü J Eur J Med Chem; 2007 Apr; 42(4):477-86. PubMed ID: 17349719 [TBL] [Abstract][Full Text] [Related]
9. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735 [TBL] [Abstract][Full Text] [Related]
11. Structural investigations of anthranilimide derivatives by CoMFA and CoMSIA 3D-QSAR studies reveal novel insight into their structures toward glycogen phosphorylase inhibition. Saqib U; Kumar B; Siddiqi MI SAR QSAR Environ Res; 2011; 22(5-6):411-49. PubMed ID: 21607894 [TBL] [Abstract][Full Text] [Related]
12. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity. Liao SY; Qian L; Miao TF; Lu HL; Zheng KC Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135 [TBL] [Abstract][Full Text] [Related]
13. Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug. Tsitsanou KE; Skamnaki VT; Oikonomakos NG Arch Biochem Biophys; 2000 Dec; 384(2):245-54. PubMed ID: 11368311 [TBL] [Abstract][Full Text] [Related]
14. Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors. Taha MO; AlDamen MA J Med Chem; 2005 Dec; 48(25):8016-34. PubMed ID: 16335926 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study. Tafi A; Anastassopoulou J; Theophanides T; Botta M; Corelli F; Massa S; Artico M; Costi R; Di Santo R; Ragno R J Med Chem; 1996 Mar; 39(6):1227-35. PubMed ID: 8632429 [TBL] [Abstract][Full Text] [Related]
16. CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors. Shashi Nayana MR; Sekhar YN; Siva Kumari N; Mahmood SK; Ravikumar M Eur J Med Chem; 2008 Jun; 43(6):1261-9. PubMed ID: 17825954 [TBL] [Abstract][Full Text] [Related]
17. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies. Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997 [TBL] [Abstract][Full Text] [Related]
18. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies. Wen X; Sun H; Liu J; Cheng K; Zhang P; Zhang L; Hao J; Zhang L; Ni P; Zographos SE; Leonidas DD; Alexacou KM; Gimisis T; Hayes JM; Oikonomakos NG J Med Chem; 2008 Jun; 51(12):3540-54. PubMed ID: 18517260 [TBL] [Abstract][Full Text] [Related]
19. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models. Puntambekar DS; Giridhar R; Yadav MR Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576 [TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]